NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
August 9, 2024 — Clene Inc., a biopharmaceutical company, is featured in the BioMedWire Podcast for its unique approach to treating neurodegenerative diseases such as ALS and MS. With a focus on improving mitochondrial health and protecting neuronal function, Clene's mission offers hope for patients and potential advancements in biopharmaceutical research.
August 9, 2024 — Dr. Patrick Porter, Ph.D., receives Conscious Award for 'Health & Wellness' at the 2nd Annual 4BIDDEN Conscious Awards in Miami, FL, for his pioneering work in brain fitness and wellness through BrainTap technology.
August 8, 2024 — Annovis Bio releases preclinical data showing the synergistic effect of buntanetap in enhancing cognition in Alzheimer’s mouse model, indicating potential breakthrough in treatment.
August 8, 2024 — Clene (NASDAQ: CLNN) releases Q2 2024 financial results and provides updates on CNM-Au8(R) programs for treating ALS and Rett Syndrome. The company's potential new drug application offers hope to patients with critical time needs.
August 8, 2024 — Clene (NASDAQ: CLNN) releases Q2 2024 financial results and updates on CNM-Au8(R) programs. Optimism about potential submission of new drug application for ALS and Rett Syndrome treatment.
August 8, 2024 — CheersAI, an innovative mental health support platform designed by high school students, offers a simple and accessible way for students to find support during challenging times. Created by co-founders Dhruv Reddy, Balaji Prasanna Venkatesh, and Rithvik Rathinasabapathy, the platform provides a non-judgmental AI therapist accessible 24x7, a supportive chat experience, and complete privacy and confidentiality, all free of cost.
August 8, 2024 — hyperCORE International expands its clinical trial capabilities with the addition of CaRe Clinic, a multi-specialty research organization in Alberta, Canada.
August 8, 2024 — Dr. Kyle S. Owens, MD, recognized as a 2024 Castle Connolly Rising Star. Lockhart Matter Dermatology & Aesthetic Center to open new Plano location in September 2024.
August 8, 2024 — Psych Choices of the Delaware Valley welcomes Mallory Mizvitowicz, a distinguished Psychiatric Nurse Practitioner, to their team, enhancing their capacity to serve patients seeking medication management and integrated therapeutic care.
August 8, 2024 — NEC Bio Therapeutics and AGC Biologics announce a significant collaboration to advance the production of NECVAX-NEO1, a personalized cancer vaccine targeting patient-specific tumor neoantigens. This collaboration represents a major advancement in personalized cancer treatments and has the potential to revolutionize the way cancer is treated, offering new hope to countless individuals battling the disease.
August 7, 2024 — Annovis Bio reports preclinical data showing the synergistic effect of buntanetap and dulaglutide in a mouse model of Alzheimer’s disease, offering promise for more effective treatment options and improved cognitive function.
August 7, 2024 — Clene Inc. is pioneering new treatments for neurodegenerative diseases such as ALS, MS, and PD, offering hope for improved quality of life and better health outcomes.
August 7, 2024 — Clene (NASDAQ: CLNN) is advancing in the treatment of ALS, MS, and PD with its innovative nanotherapeutic platform and lead drug candidate, CNM-Au8.
August 7, 2024 — Iteris Inc. and Sumitomo Electric Industries join forces to introduce an advanced pedestrian safety solution, aiming to reduce fatalities and enhance pedestrian safety in North America. This collaboration aligns with the Vision Zero initiative and addresses transportation equity to eliminate traffic fatalities and serious injuries.
August 7, 2024 — Dr. Susanne Lockhart recognized as a 2024 Castle Connolly Top Doctor. Dermatologist at Lockhart Matter Dermatology & Aesthetic Center, specializing in skin conditions and cancer prevention.
August 7, 2024 — Dr. Christie Matter, MD, recognized as a 2024 Castle Connolly Top Doctor for her outstanding dermatological expertise. Learn about the expansion of Lockhart Matter Dermatology & Aesthetic Center to a new location in Plano.
August 6, 2024 — Alzamend Neuro, Inc. (NASDAQ:ALZN) partners with MGH for Phase II trial of next-generation lithium therapeutic drug candidate for bipolar disorder and Alzheimer's disease, potentially revolutionizing mental health treatment.
August 6, 2024 — Annovis Bio (ANVS) featured in The Bell2Bell Podcast for its transformative therapies targeting Alzheimer’s and Parkinson’s diseases. Learn about the promising phase 3 data of buntanetap and its potential impact on patient care.
August 6, 2024 — Clene (NASDAQ: CLNN) to present at Canaccord Genuity conference, showcasing efforts to treat ALS and MS. Webcast on August 13, 2024. Investors gain valuable insights.
August 6, 2024 — Clene (NASDAQ: CLNN) to present at Canaccord Genuity 44th Annual Growth Conference. Learn about the company's focus on treating ALS and MS. Watch the live webcast for valuable insights.